Outlook Therapeutics Ownership & Insider Activity

Outlook Therapeutics (OTLK) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 4.5% of shares outstanding. Institutional investors hold 7.2%. Over the past 90 days, insiders made 3 purchases worth $2.5M.

Shares Outstanding

242.673M

Shares Float

229.084M

Insider Shares Owned

10.990M

Insider % Owned

4.5%

Institutional Shares Held

17.596M

Institutional % Held

7.2%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$2.5M total

Sales (90d)

Net Activity

Net Buying

Net Value (90d)

$2.5M

Outlook Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Aug 14, 2026	Charles Robert Jahr	CHIEF EXECUTIVE OFFICER	BUY	151.515K	—	—
Aug 14, 2026	Lawrence Kenyon	CHIEF FINANCIAL OFFICER	BUY	101.010K	—	—
Aug 12, 2026	Ghiath Sukhtian, Investments Ventures GMS	—	BUY	2.525M	$0.99	$2.5M
Jul 29, 2026	Ghiath Faisal Sukhtian	DIRECTOR	BUY	95.398K	$1.05	$100K
Jun 2, 2026	Munther Yezan Haddadin	DIRECTOR	BUY	29.000K	$0.83	$24K
May 28, 2026	Ghiath Sukhtian, Investments Ventures GMS	—	BUY	8.540M	$0.59	$5.0M
May 27, 2026	Ghiath Faisal Sukhtian	DIRECTOR	BUY	122.174K	$0.41	$50K
May 26, 2026	Munther Yezan Haddadin	DIRECTOR	BUY	34.000K	$0.44	$15K
May 26, 2026	RANDY THURMAN	DIRECTOR	BUY	5.000K	$0.43	$2K
May 26, 2026	KURT HILZINGER	DIRECTOR	BUY	400.000K	$0.44	$177K